Table 4.
Clinical and laboratory findings of adults patients (> 16 y) with and without pneumonia (n = 156)
| Group | No Pneumonia (n = 120) |
Pneumonia (n = 36) |
P |
|---|---|---|---|
| Clinical characteristics | |||
| Mean age (y) | 35 ± 17 | 48 ± 22 | 0.002 |
| Male/Female | 53/67 | 11/25 | NS |
| Duration of fever (d) | |||
| Before admission | 1.8 ± 1.2 | 2.1 ± 1.5 | NS |
| Total | 3.2 ± 2.9 | 3.9 ± 2.3 | NS |
| Hospitalization (d) | 5.2 ± 2.9 | 7.9 ± 3.8 | < 0.001 |
| Oseltamivir, < 48 h* | 103 (86.7) | 29 (80.6) | NS |
| Laboratory findings | |||
| Haemoglobin (g/dL) | 13.4 ± 2.0 | 12.5 ± 2.1 | 0.02 |
| Leukocyte (×109//L) | 6.2 ± 2.4 | 7.9 ± 3.5 | 0.009 |
| Neutrophil (%) | 64 ± 15 | 76 ± 12 | < 0.001 |
| Lymphocyte (%) | 24 ± 14 | 16 ± 9 | < 0.001 |
| Monocyte (%) | 10 ± 4 | 7 ± 4 | 0.001 |
| Platelet (×109/L) | 205 ± 50 | 201 ± 69 | NS |
| CRP (mg/dL) | 2.3 ± 4.0 | 6.6 ± 6.5 | 0.001 |
| ESR (mm/h) | 22 ± 19 | 35 ± 22 | 0.001 |
a Number (%) of patients who received oseltamivir treatment within 48 h of fever onset